Carmed Pharmaceuticals Expands U.S. Reach with OneLavi.com Launch

Carmed Pharmaceuticals' Strategic U.S. Expansion

Carmed Pharmaceuticals, a distinguished Turkey-based company, is making significant strides in the U.S. market with the launch of its products on OneLavi.com, a curated online marketplace specializing in health, beauty, and wellness brands. This strategic move represents a milestone in Carmed's ongoing efforts to broaden its reach in the United States, following its announced plans to expand through multiple digital retail channels, including Amazon. Founded on the principles of combining traditional botanical knowledge with modern pharmaceutical methodologies, Carmed is dedicated to developing standardized formulations that enhance immune resilience, cellular health, and overall physiological balance.

Innovative Formulations Now Accessible on OneLavi.com

Through OneLavi.com, U.S. consumers now have the opportunity to purchase several of Carmed Pharmaceuticals' flagship products. These include the Vacrol® Kids Spray, developed to support upper respiratory wellness and microbial balance in children, and the S-Mix®, a formulation designed to bolster immune function and healthy cellular activity. Additionally, the Vacrol® Capsule and the Vacrol-M® Capsule offer unique botanical formulations aimed at maintaining microbial balance and supporting respiratory wellness. Notably, Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified, ensuring their wide appeal to health-conscious consumers.

Commitment to Scientific Research and Quality

Carmed Pharmaceuticals' reputation is built upon a robust foundation of scientific research and collaboration with academic institutions, laboratories, and medical researchers. In January 2026, a study published in the peer-reviewed journal Plants examined the efficacy of Vacrol® and S-Mix® in preclinical models, contributing to the broader scientific understanding of carvacrol-based formulations. While Carmed emphasizes that these studies do not serve as evidence for diagnosing or treating diseases, they highlight the company's dedication to advancing botanical bioactivity and formulation science. The launch on OneLavi.com aligns with Carmed's long-term strategy of establishing itself as a trusted international wellness brand in the U.S., emphasizing scientific credibility, regulatory alignment, and consumer accessibility. As Carmed continues its expansion, consumers are encouraged to explore the innovative offerings on platforms like OneLavi, where quality and transparency are at the forefront.

By making its products available on OneLavi.com, Carmed Pharmaceuticals takes a significant step in enhancing its presence in the U.S. market, offering consumers access to scientifically-backed, high-quality botanical formulations. This expansion reflects Carmed's vision of building a trusted international wellness brand, guided by a commitment to research-driven innovation and consumer well-being.